DEFA14A: Synaptogenix Issues Corrected Proxy Card After Error in Director Nominee Listing

Sentiment:

Proxy Supplement


Synaptogenix has issued a supplemental proxy statement and corrected proxy card due to an error in the original proxy card which incorrectly listed director nominees.

Capital raiseProposal 2 seeks authorization for the issuance of shares of common stock underlying convertible preferred stock and warrants issued pursuant to a Securities Purchase Agreement dated September 10, 2024.The issuance could be in an amount equal to or in excess of 20% of the company's common stock outstanding before the issuance.

Summary

  • Synaptogenix has released a supplement to its proxy statement for the 2024 Annual Meeting of Stockholders.
  • The original proxy card incorrectly stated that Alan Tuchman, M.D. and Daniel L. Alkon, M.D. were director nominees.
  • The correct nominees are Joshua N. Silverman and William S. Singer.
  • A corrected proxy card has been issued with the correct nominees.
  • Votes cast for the incorrect nominees on the original proxy card will not be recognized.
  • Stockholders who voted for the incorrect nominees can revoke their proxy by submitting the new card or voting online or by phone.
  • The Annual Meeting date remains December 6, 2024.
  • The company has apologized for the confusion caused by the error.

Sentiment

Score: 6

Explanation: The document addresses a mistake and provides a correction, which is a neutral event. The company's response is appropriate, but the initial error is a slight negative.

Positives

  • The company promptly identified and corrected the error in the proxy card.
  • A clear process for revoking incorrect votes and submitting new votes has been provided to shareholders.
  • The company has apologized for the error, demonstrating accountability.

Negatives

  • The error in the original proxy card could cause confusion and inconvenience for shareholders.
  • The need to reissue a corrected proxy card adds to administrative costs and effort.

Risks

  • The error in the proxy card could potentially lead to shareholder dissatisfaction.
  • There is a risk that some shareholders may not receive or understand the corrected proxy information.
  • The error could raise questions about the company's internal controls and processes.

Management Comments

  • The company has apologized for any confusion this printing error may have caused.
  • The Board of Directors recommends a vote FOR proposals 2, 3, and 4 and FOR ALL the nominees for director listed in Proposal 1.

Industry Context

This type of error in proxy materials is not common but can occur, highlighting the importance of careful review and quality control in corporate communications. It is important for companies to rectify such errors quickly to maintain shareholder trust and ensure a smooth voting process.

Comparison to Industry Standards

  • The error in the proxy card is not typical for companies of this size and public listing status.
  • Most companies have robust processes to prevent such errors in proxy materials.
  • The speed and transparency with which Synaptogenix addressed the error is in line with best practices for corporate governance.

Stakeholder Impact

  • Shareholders are impacted by the need to review and potentially resubmit their proxy votes.
  • The company's reputation could be slightly impacted by the error, but the prompt correction mitigates this.

Next Steps

  • Stockholders should review the corrected proxy card and vote accordingly.
  • Stockholders who previously voted for the incorrect nominees should revoke their proxy and submit a new vote.
  • The company will hold the Annual Meeting of Stockholders on December 6, 2024.

Key Dates

DateDescription
November 7, 2024Original proxy statement filed with the SEC.
November 19, 2024Date of the supplemental proxy statement and corrected proxy card.
December 5, 2024Deadline to register for the virtual annual meeting by 11:59 p.m. ET.
December 6, 2024Date of the Annual Meeting of Stockholders at 11:00 a.m. ET.

Keywords

proxy statement, director nominees, annual meeting, proxy card, stockholders, corporate governance, voting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.